Nemonoxacin shows similar efficacy to moxifloxacin in hospitalized CAP patients
New pneumonia drug saves money while matching standard care results
This retrospective cohort study of 196 hospitalized patients with community-acquired pneumonia found that nemonoxacin injection had 100.0% c…
A new pneumonia drug saves hospital costs while working just as well as the standard treatment for patients.
Macrolide-resistant Mycoplasma pneumoniae prevalence at 94% in pediatric CAP cohort
Resistant pneumonia keeps kids sicker for days
This retrospective cohort of 71 pediatric patients in China found a 94.4% prevalence of macrolide-resistant M. pneumoniae. MRMP infections w…
In one Chinese hospital, 94% of child pneumonia cases resisted common antibiotics, leading to longer fevers and hospital stays.
tNGS in pediatric LRTIs shows higher Mycoplasma pneumoniae detection in severe vs non-severe CAP
A new test found more germs in severe pediatric pneumonia cases than mild ones.
A retrospective, single-center cohort study of 2,299 children with suspected lower respiratory tract infections found that targeted next-gen…
A new test found that severe pediatric pneumonia cases carry more germs than mild ones, revealing a link between specific microbial signatur…
Systemic Immune-Inflammation Index predicts severe community-acquired pneumonia in pediatric patients.
High Blood Markers Signal Dangerous Pneumia in Kids
This retrospective analysis evaluated 595 pediatric patients to assess the Systemic Immune-Inflammation Index (SII) for predicting severe pn…
A simple blood test number called SII helps doctors spot dangerous pneumonia in children before their lungs fill with fluid.
Pyroptosis endotypes and malnutrition linked to mortality in older adults with community-acquired pneumonia
High inflammation markers linked to higher death risk in older pneumonia patients
This retrospective cohort study evaluated 282 hospitalized older adults (aged ≥75 years) with community-acquired pneumonia. Researchers asse…
Older pneumonia patients with high inflammation markers faced a 57.5% death risk, while those with low levels had only 1.2% mortality within…
Contezolid shows 80% clinical cure rate in small pneumonia study with good pulmonary penetration
Can a new oral antibiotic effectively treat pneumonia?
A prospective, single-center, open-label study of 15 adults with primarily community-acquired pneumonia found oral contezolid 800 mg twice d…
A new oral antibiotic called contezolid cured pneumonia in 80% of patients and reached lung infection sites at levels four times higher than…
U.S. pediatric hospitals report increase in Mycoplasma pneumoniae pneumonia discharges in children
Report notes increase in childhood pneumonia hospitalizations linked to Mycoplasma bacteria
An observational report from U.S. pediatric hospitals indicates an increase in hospital discharges of children with Mycoplasma pneumoniae-as…
U.S. pediatric hospitals saw more children hospitalized for Mycoplasma pneumonia in 2024, signaling a pattern health officials are watching.